The cholinergic hypothesis of Alzheimer's disease: a review of progress - Test2 - elhamkhani - TriplyDB

The cholinergic hypothesis of Alzheimer's disease: a review of progress

The cholinergic hypothesis of Alzheimer's disease: a review of progress

http://www.wikidata.org/entity/Q22242019

about

sameAs

The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders Single nucleotide polymorphism of the human high affinity choline transporter alters transport rate Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients Acetyl-CoA the key factor for survival or death of cholinergic neurons in course of neurodegenerative diseases Neuropharmacological review of the nootropic herb Bacopa monnieri Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease Reprint of: From the 90׳s to now: A brief historical perspective on more than two decades of estrogen neuroprotection Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal Compounds Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels The Response to Oxidative DNA Damage in Neurons: Mechanisms and Disease Melatonin and Other Tryptophan Metabolites Produced by Yeasts: Implications in Cardiovascular and Neurodegenerative Diseases Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology PET Imaging of Epigenetic Influences on Alzheimer's Disease Proteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer's Disease The Role of Oxidative Stress-Induced Epigenetic Alterations in Amyloid-β Production in Alzheimer's Disease Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal Huprine derivatives as sub-nanomolar human acetylcholinesterase inhibitors: from rational design to validation by X-ray crystallography The pharmacology and therapeutic potential of (-)-huperzine A.Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial Donepezil impairs memory in healthy older subjects: behavioural, EEG and simultaneous EEG/fMRI biomarkers Insulin Regulates the Activity of the High-Affinity Choline Transporter CHT No Acute Effects of Choline Bitartrate Food Supplements on Memory in Healthy, Young, Human Adults Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity The functional therapeutic chemical classification system Integrative Understanding of Emergent Brain Properties, Quantum Brain Hypotheses, and Connectome Alterations in Dementia are Key Challenges to Conquer Alzheimer's Disease In vitro Antioxidant and Enzymatic Approaches to Evaluate Neuroprotector Potential of Blechnum Extracts without Cytotoxicity to Human Stem Cells Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease.Long-Term Cholinesterase Inhibitor Therapy for Alzheimer's Disease: Practical Considerations for the Primary Care Physician Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Synaptic alterations in the vestibulocerebellar system in Alzheimer's disease--a Golgi and electron microscope study.Neural correlates of true and false memory in mild cognitive impairment.Structural insight into GRIP1-PDZ6 in Alzheimer's disease: study from protein expression data to molecular dynamics simulations.The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.Mechanics of channel gating of the nicotinic acetylcholine receptor.NO-flurbiprofen reduces amyloid-beta, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade.Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease.

P2860

Q22241325-6822A0C1-C1F2-464D-8B3D-BC33C846373C Q24306874-D3581F31-4E9C-412A-866F-734792287843 Q24554505-882DEDDC-B525-4968-AF67-EAB595D6AD69 Q24608842-09147AA8-F7DC-4216-A318-5837500FEF87 Q24630774-A992CA40-65EF-4547-B119-86A4C363712D Q24671886-B8F16E3D-1667-4BC5-815B-60B1A0532FCE Q26741247-875014D1-34FF-437A-9F1D-785C86FD1AE2 Q26744401-11555970-46DB-40F8-B786-183CC3F9A504 Q26749061-B08DA92F-CE5E-412C-A264-F9690AB9E97C Q26749755-693914D1-9789-4FD9-99EA-0D035CE11993 Q26751302-FDB9487F-4B8F-4C8F-B898-49BB09741198 Q26768287-9DBF158F-F864-4095-B711-3552337CD8C8 Q26772733-3EBBEF38-62B0-4638-8C9A-5C52F83EFDDB Q26774743-4D8D11C6-526E-4A0B-B95B-3F976FEE8FD2 Q26776178-CDC43869-D2AC-41C8-B204-B67C36771BB4 Q26777933-6F8B419F-34F9-4809-A3C3-B4CD990BA8E4 Q26778776-AC7E2F7B-7471-4DE2-8BC8-C3F8FA8ABBC3 Q26783344-F8E70A2C-91E9-42FD-A67A-5E64DC55F346 Q27675368-F8819621-274D-4A3D-8A28-CE9E71ED77F6 Q27691305-586350EC-DC67-44C7-8FF0-AF490EB37E2B Q28070156-11D73BB5-DCCC-4293-84A6-6A8E64F28D50 Q28287100-6954FC69-E090-4280-9D78-D4E7525C45B7 Q28362149-E4D5EC0B-851F-411A-B194-B552353B61C4 Q28476847-14FA509D-3AF3-43DD-B9B2-7C6B8F7503EC Q28546435-5D5850E7-4816-4E3B-9DA3-F3EE1F0B4A8F Q28552133-72523F77-EAAC-46E3-9646-D92BB21792AC Q28586552-4C3FEF0E-6CF9-472F-9EDA-98060FB39FB5 Q28657672-E8D966AC-7A2E-4592-B6C3-51B0B4369D5A Q28744010-F982C3D4-1577-4CDD-AEDB-4B0795C043B5 Q28829842-AD9CDD8F-1A37-442E-8A75-61152C09A98B Q30394816-D82BCD3B-BE6B-46FE-B0A5-C3C3169FEABD Q30433785-F17E56D6-7A60-4623-ABB4-F08C5DBD1E63 Q30446460-41BAD92B-16AD-466C-8E38-893ABF3A2290 Q31017071-37139117-EDA7-4276-8500-11F86C41DC62 Q31106059-E6434F25-B156-4C1A-95D7-6B2FFC67AD17 Q31115270-F927F189-3CF5-4ED2-B0F6-39E55397756E Q33165801-0D9DAC2B-3B2A-49F6-8154-6EEA6955BC3F Q33316816-4FA8225F-5B34-4D1A-8F13-CBCD615871FE Q33496256-39DE2A92-C297-408D-A441-82A628D82E92 Q33586027-2107436A-1C75-434C-8F33-92727AC7A2B2

P2860

The cholinergic hypothesis of Alzheimer's disease: a review of progress

http://www.wikidata.org/entity/Q22242019

description

1999 nî lūn-bûn

@nan

1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

The cholinergic hypothesis of Alzheimer's disease: a review of progress

@ast

The cholinergic hypothesis of Alzheimer's disease: a review of progress

@en

The cholinergic hypothesis of Alzheimer's disease: a review of progress

@en-gb

The cholinergic hypothesis of Alzheimer's disease: a review of progress

@nl

type

label

The cholinergic hypothesis of Alzheimer's disease: a review of progress

@ast

The cholinergic hypothesis of Alzheimer's disease: a review of progress

@en

The cholinergic hypothesis of Alzheimer's disease: a review of progress

@en-gb

The cholinergic hypothesis of Alzheimer's disease: a review of progress

@nl

prefLabel

The cholinergic hypothesis of Alzheimer's disease: a review of progress

@ast

The cholinergic hypothesis of Alzheimer's disease: a review of progress

@en

The cholinergic hypothesis of Alzheimer's disease: a review of progress

@en-gb

The cholinergic hypothesis of Alzheimer's disease: a review of progress

@nl

P1433

Q22242019-5BD31F89-A5DC-41A9-9FE6-532A59A30788

P1476

Q22242019-2B7DEDB6-4A6F-4048-B1C5-89EBA72D9315

P2093

Q22242019-17DC74C1-EFC3-4C62-9540-124CE9AC8E82

Q22242019-25D359FC-780C-4BBF-9816-E15155D9404F

Q22242019-60D1D988-79F5-426B-B026-AB0E0E101683

Q22242019-77B117BB-1452-4182-8C2F-35AB31D721D2

P2860

Q22242019-01702326-717F-416B-8153-F618146E6D90

Q22242019-019C5836-F1EB-47A6-B88E-3C4D4B705304

Q22242019-027A8CDE-D61C-4F14-973C-E51ABAB97E38

Q22242019-0315E98C-3C60-40EA-8E7C-F380A16B9090

Q22242019-0587C51B-77A1-4508-96C9-80CBC2B3F1B0

Q22242019-0701C624-C2DA-4E24-AE5A-31B79C3E4795

Q22242019-09F3F2FB-B2A2-4417-B787-1DAC3CF5F63F

Q22242019-0A0D618E-3B12-4308-BEA5-B492337182CC

Q22242019-0D61000B-2E3E-4176-B435-2DAC1653DA8C

Q22242019-0EB12871-5177-4042-A40A-928F43829DAC

P304

Q22242019-EBABC1E0-E0F5-448A-BED7-1408A0FD04F6

P31

Q22242019-BD241B41-F2D5-40EC-84D3-46D1B29C15A4

P3181

Q22242019-38538353-565B-4989-89EC-2F43E655FA29

P356

Q22242019-D9285094-2E27-444E-96F5-098EA6887768

P407

Q22242019-817D4CFF-5A2A-4E2B-9851-654C86C08DEC

P433

Q22242019-18ED4651-0EF4-4EC5-A172-D87AC6E17FF7

P478

Q22242019-FD9C87B9-84E3-4C4A-B1D7-DE370E7980FE

P577

Q22242019-B5193E4B-BDCA-48BD-861D-CAD9F9991705

P698

Q22242019-74F38A36-6631-4558-B819-24713F2A9F0F

P921

Q22242019-4D1B3AB0-DE89-455D-88F7-2E1E4BC89EFB

P932

Q22242019-1F491BAD-0394-4A1D-A700-A72C4462B001

P3181

P356

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

The cholinergic hypothesis of Alzheimer's disease: a review of progress

@en

P2093

A. M Palmer

http://www.w3.org/2001/XMLSchema#string

G. K Wilcock

http://www.w3.org/2001/XMLSchema#string

M. Snape

http://www.w3.org/2001/XMLSchema#string

P. T Francis

http://www.w3.org/2001/XMLSchema#string

P2860

Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Three-dimensional structure of acetylcholinesterase and of its complexes with anticholinesterase drugs

The cholinergic hypothesis of geriatric memory dysfunction

Inhibition of human brain and RBC acetylcholinesterase (AChE) by heptylphysostigmine (HPTL)

Amyloid deposition as the central event in the aetiology of Alzheimer's disease

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease.

Alzheimer's disease: a correlative study

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease.

P304

137-147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

131436

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/JNNP.66.2.137

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

1999-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10071091

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

1736202

http://www.w3.org/2001/XMLSchema#string